es.invokana.comHomepage | INVOKANA® (canagliflozin)

es.invokana.com Profile

es.invokana.com

Maindomain:invokana.com

Title:Homepage | INVOKANA® (canagliflozin)

Description:Welcome to the official INVOKANA® website. Talk to your doctor about INVOKANA® today. See full Prescribing & Safety Information.

Discover es.invokana.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site

es.invokana.com Information

Website / Domain: es.invokana.com
HomePage size:66.087 KB
Page Load Time:0.159781 Seconds
Website IP Address: 104.18.17.131
Isp Server: CloudFlare Inc.

es.invokana.com Ip Information

Ip Country: United States
City Name: Phoenix
Latitude: 33.448379516602
Longitude: -112.07404327393

es.invokana.com Keywords accounting

Keyword Count

es.invokana.com Httpheader

Date: Thu, 13 May 2021 18:38:51 GMT
Content-Type: text/html; charset=utf-8
Transfer-Encoding: chunked
Connection: keep-alive
X-Drupal-Cache: HIT
Content-Security-Policy: "default-src *; script-src unsafe-eval self unsafe-inline https:; object-src self *.youtube.com youtube.com; style-src * unsafe-inline; img-src * data:; frame-src *; font-src * data:; connect-src *; media-src * blob:; worker-src self blob:;", Strict-Transport-Security: max-age=600
Content-Language: en
X-Frame-Options: SAMEORIGIN
X-UA-Compatible: IE=edge
X-Generator: Drupal 7 (http://drupal.org)
Link: https://www.invokana.com/; rel="canonical",https://www.invokana.com/node/191; rel="shortlink"
Cache-Control: public, max-age=21600
Last-Modified: Thu, 13 May 2021 14:58:31 GMT
Expires: Sun, 19 Nov 1978 05:00:00 GMT
Vary: Cookie,Accept-Encoding
X-Request-ID: v-8223bbc0-b405-11eb-8a64-635e96e360a4
X-AH-Environment: prod
Age: 9000
Via: varnish
X-Cache: HIT
X-Cache-Hits: 989
CF-Cache-Status: DYNAMIC
cf-request-id: 0a089f50d700000e92e48cd000000001
Expect-CT: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
Server: cloudflare
CF-RAY: 64ee0194895c0e92-PHL
Content-Encoding: gzip

es.invokana.com Meta Info

content="width=device-width, initial-scale=1.0" name="viewport"/
content="telephone=no" name="format-detection"/
content="text/html; charset=utf-8" http-equiv="Content-Type"
content="Welcome to the official INVOKANA® website. Talk to your doctor about INVOKANA® today. See full Prescribing & Safety Information." name="description"
content="INVOKANA®" name="keywords"/
content="Drupal 7 (http://drupal.org)" name="generator"/
content="Invokana" property="og:site_name"/
content="no-transform" http-equiv="cache-control"/
content="article" property="og:type"/
content="https://www.invokana.com/home" property="og:url"/
content="INVOKANA® (canagliflozin)" property="og:title"/
content="INVOKANA® (canagliflozin) Official Website" property="og:description"/
content="2020-11-04T15:08:14+00:00" property="og:updated_time"/
content="summary" name="twitter:card"/
content="https://www.invokana.com/home" name="twitter:url"/
content="INVOKANA® (canagliflozin)" name="twitter:title"/
content="INVOKANA® (canagliflozin) Official Website" name="twitter:description"/
content="2019-10-17T02:17:04+00:00" property="article:published_time"/
content="2020-11-04T15:08:14+00:00" property="article:modified_time"/

104.18.17.131 Domains

Domain WebSite Title

es.invokana.com Similar Website

Domain WebSite Title
invokana.comHomepage | INVOKANA® (canagliflozin)
es.invokana.comHomepage | INVOKANA® (canagliflozin)
origin.invokana.comHomepage INVOKANA® canagliflozin

es.invokana.com Traffic Sources Chart

es.invokana.com Alexa Rank History Chart

es.invokana.com aleax

es.invokana.com Html To Plain Text

Skip to main content Google Tag Manager Product Information INVOKANA ® INVOKAMET ® XR INVOKAMET ® Medication Guide INVOKANA ® INVOKAMET ® XR INVOKAMET ® Important Safety Information For Healthcare Professionals For US Patients Toggle navigation About INVOKANA ® What is INVOKANA ® ? How INVOKANA ® Works What are INVOKAMET ® XR and INVOKAMET ® ? FAQs Diabetic Kidney Disease Type 2 Diabetes Savings and Support Product Information INVOKANA ® INVOKAMET ® XR INVOKAMET ® Medication Guide INVOKANA ® INVOKAMET ® XR INVOKAMET ® Important Safety Information For Healthcare Professionals For US Patients If you have type 2 diabetes—your kidneys need attention! LEARN MORE INVOKANA ® is the first type 2 diabetes medication proven in a landmark clinical study to lower the risk of: End-stage kidney disease (ESKD) Worsening of kidney function Cardiovascular death Hospitalization for heart failure In adults with type 2 diabetes and diabetic kidney disease (nephropathy) with a certain amount of protein in the urine. INVOKANA ® also: Lowers the risk of heart attack , stroke , or cardiovascular death in people with type 2 diabetes and established cardiovascular disease. Lowers blood sugar (A1C) in adults with type 2 diabetes, along with diet and exercise. LEARN MORE Type 2 diabetes can really hurt your kidneys —and you may not even know it’s happening. Our kidneys work hard to do some very important things for us. But unfortunately type 2 diabetes can cause diabetic kidney disease , a serious situation that can have no early symptoms and can lead to dialysis, transplant, hospitalization for heart failure, and even death. What should you do? What’s an eGFR number —and why is it important to know it? Learn the answers to these important questions and more here. GET THE FACTS Janssen wants to help you explore cost support options for INVOKANA ® . We’d like to help! Learn if you’re eligible for savings options, and get support. EXPLORE SAVINGS OPTIONS WHAT IS INVOKANA ® ? INVOKANA ® (canagliflozin) is a prescription medicine used: along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease to reduce the risk of end-stage kidney disease (ESKD), worsening of kidney function, cardiovascular death, and hospitalization for heart failure in adults with type 2 diabetes mellitus and diabetic kidney disease (nephropathy) with a certain amount of protein in the urine INVOKANA ® is not for people with type 1 diabetes. It may increase their risk of diabetic ketoacidosis (increased ketones in blood or urine). INVOKANA ® is not used to lower blood sugar (glucose) in adults with type 2 diabetes with severe kidney problems. It is not known if INVOKANA ® is safe and effective in children under 18 years of age. IMPORTANT SAFETY INFORMATION INVOKANA ® can cause serious side effects, including: Amputations. INVOKANA ® may increase your risk of lower-limb amputations. Amputations mainly involve removal of the toe or part of the foot; however, amputations involving the leg, below and above the knee, have also occurred. Some people had more than one amputation, some on both sides of the body. You may be at a higher risk of lower-limb amputation if you: have a history of amputation, have heart disease or are at risk for heart disease, have had blocked or narrowed blood vessels (usually in leg), have damage to the nerves (neuropathy) in the leg, or have had diabetic foot ulcers or sores. Call your doctor right away if you have new pain or tenderness, any sores, ulcers, or infections in your leg or foot. Your doctor may decide to stop your INVOKANA ® for a while if you have any of these signs or symptoms. Talk to your doctor about proper foot care. Dehydration. INVOKANA ® can cause some people to become dehydrated (the loss of too much body water), which may cause you to feel dizzy, faint, lightheaded, or weak, especially when you stand up (orthostatic hypotension). There have been reports of sudden worsening of kidney function in people with type 2 diabetes who are taking INVOKANA ® . You may be at higher risk of dehydration if you take medicines to lower your blood pressure (including diuretics [water pills]), are on a low sodium (salt) diet, have kidney problems, or are 65 years of age or older. Talk to your doctor about what you can do to prevent dehydration including how much fluid you should drink on a daily basis. Call your healthcare provider right away if you reduce the amount of food or liquid you drink, for example if you cannot eat or you start to lose liquids from your body, for example from vomiting, diarrhea, or being in the sun too long. Ketoacidosis (increased ketones in your blood or urine). Ketoacidosis has happened in people who have type 1 or type 2 diabetes, during treatment with INVOKANA ® . Ketoacidosis has also happened in people with diabetes who were sick or who had surgery during treatment with INVOKANA ® . Ketoacidosis is a serious condition, which may need to be treated in a hospital. Ketoacidosis may lead to death. Ketoacidosis can happen with INVOKANA ® even if your blood sugar is less than 250 mg/dL. Stop taking INVOKANA ® and call your doctor right away if you get any of the following symptoms: nausea, vomiting, stomach-area pain, tiredness, or trouble breathing. If you get any of these symptoms during treatment with INVOKANA ® , if possible, check for ketones in your urine, even if your blood sugar is less than 250 mg/dL. Vaginal yeast infection. Symptoms of a vaginal yeast infection include: vaginal odor, white or yellowish vaginal discharge (discharge may be lumpy or look like cottage cheese), or vaginal itching. Yeast infection of the skin around the penis (balanitis or balanoposthitis). Swelling of an uncircumcised penis may develop that makes it difficult to pull back the skin around the tip of the penis. Other symptoms include: redness, itching, or swelling of the penis; rash of the penis; foul-smelling discharge from the penis; or pain in the skin around penis. Talk to your doctor about what to do if you get symptoms of a yeast infection of the vagina or penis. Do not take INVOKANA ® if you: are allergic to canagliflozin or any of the ingredients in INVOKANA ® . Symptoms of allergic reaction to INVOKANA ® may include: rash; raised red patches on your skin (hives); swelling of the face, lips, mouth, tongue, and throat that may cause difficulty in breathing or swallowing are on kidney dialysis Before taking INVOKANA ® , tell your doctor if you: have a history of amputation; have heart disease or are at risk for heart disease; have had blocked or narrowed blood vessels (usually in leg); have damage to the nerves (neuropathy) in your leg; have had diabetic foot ulcers or sores; have kidney problems; have liver problems; have a history of urinary tract infections or problems with urination; are on a low sodium (salt) diet; are going to have surgery (your doctor may stop your INVOKANA ® before you have surgery; talk to your doctor if you are having surgery about when to stop taking INVOKANA ® and when to start it again); are eating less or there is a change in diet; have or have had pancreas problems; drink alcohol very often (or drink a lot of alcohol in the short-term); or ever had an allergic reaction to INVOKANA ® . Tell your doctor if you are or plan to become pregnant, are breastfeeding, or plan to breastfeed. INVOKANA ® may harm your unborn baby. If you become pregnant while taking INVOKANA ® , tell your doctor right away. INVOKANA ® may pass into your breast milk and may harm your baby. Do not breastfeed while taking INVOKANA ® . Tell your doctor about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements . Especially tell your doctor if you take diuretics (water pills), rifampin (used to treat or prevent tuber...

es.invokana.com Whois

"domain_name": [ "INVOKANA.COM", "invokana.com" ], "registrar": "Key-Systems GmbH", "whois_server": "whois.rrpproxy.net", "referral_url": null, "updated_date": "2019-07-14 15:00:59", "creation_date": "2012-08-15 13:06:27", "expiration_date": "2020-08-15 13:06:27", "name_servers": [ "NS1.JNJ.COM", "NS3.JNJ.COM", "NS5.JNJ.COM", "ns1.jnj.com", "ns3.jnj.com", "ns5.jnj.com" ], "status": "clientTransferProhibited https://icann.org/epp#clientTransferProhibited", "emails": [ "abuse@key-systems.net", "abusereport@key-systems.net", "info@domain-contact.org" ], "dnssec": "unsigned", "name": "REDACTED FOR PRIVACY", "org": "REDACTED FOR PRIVACY", "address": "REDACTED FOR PRIVACY", "city": "REDACTED FOR PRIVACY", "state": "New Jersey", "zipcode": "REDACTED FOR PRIVACY", "country": "US"